Eye Treatment Considerations

Not an actual patient
Photograph of a woman during an eye exam with a female doctor

Overview

Early detection and consistent management are critical in slowing the progression of corneal crystal accumulation associated with cystinosis. Treatment adherence, patient education, and ongoing collaboration among the specialists on the healthcare team may improve overall treatment outcomes.

Patient Adherence

Improving Adherence1,2

Oral treatment3-5

  • Should be initiated as soon as possible and continued for life
  • Due to the cornea’s avascularity, oral treatment does not address corneal cystine crystals
Designed image of an eye

Topical ophthalmic treatment with cystine-depleting eye drops3

  • Only topical treatment can reduce corneal cystine crystal accumulation3
  • If you have a patient with cystinosis, discover an FDA-Approved treatment option for corneal cystine crystals.
Learn More

Patient Education

Strategies to improve patient understanding

Because cystinosis is a chronic and complex disorder, patient education is critical and can help caregivers and families manage the challenges they may experience.

Potential challenges with administration of eye drops:

  • Not administering the eye drops correctly
  • Side effects
  • Not adhering to dosage frequency
  • Not adhering to treatment because they do not see or understand a benefit

Strategies to Improve Adherence

Adherence Issue Adherence Strategies

Not administering the eye drop correctly

  • Review technique to ensure proper administration
  • Educate on the correct eye drop administration technique

Side effects

  • Manage expectations and educate on potential side effects
  • Educate on benefits of treatment and potential consequences of not treating the eye

Remembering to administer eye drops

  • Suggest using reminder techniques such as alarms or text messages

Frequency of administration

  • Discuss or determine the best time for the patient to administer eye drops

Not seeing or understanding the benefits of treatment

  • Educate on the progression of crystal accumulation and potential long-term consequences
  • Discuss long-term benefits of using eye drops
  • Suggest keeping track of symptoms
  • Establish a benchmark to visualize and measure progress

Tracking Progress

Assessing Disease Progression

Periodic slit-lamp exams are useful for assessing the density of corneal cystine crystals as the disease progresses. Cystine crystals can be tracked over time using a corneal cystine crystal score (CCCS) that ranges from 0 (clear) to 3.00 (packed with crystals), as shown in the images below.*,†

1yo
1 y.o.

CCCS = 0.25
2yo
2 y.o.

CCCS = 0.25
7yo
7 y.o.

CCCS = 2.75
12yo
12 y.o.

CCCS = 3.00
>20 y.o.

CCCS = 3.00

Images adapted from Gahl et al 2000, with permission from the publisher.

*Photos from a slit-lamp exam are compared to a standard library of National Institutes of Health (NIH) photos of corneas containing cystine crystals at different densities. (For more information, see Gahl 2000.)

†Other methods of quantifying corneal cystine crystals – in vivo confocal microscopy (IVCM) and anterior-segment optical coherence tomography (AS-OCT) – may provide more precise assessments and additional clinically relevant information.

Coordinating Care

Cystinosis Treatment Team

Cystinosis affects multiple organs and systems requiring a multidisciplinary approach to treatment. Bringing together a number of specialists to address and treat symptoms is essential for:

  • Delivering high-quality clinical care
  • Optimizing the patient experience for better medication adherence
  • Mitigating complications, including vision loss
Photograph of healthcare professional
Download this coordination of care resource for your patients.
Coordination of Care Resource

REFERENCES: 1. Elmonem MA et al. Orphanet J Rare Dis. 2016;11:47. doi:10.1186/s13023-016-0426-y. 2. Nesterova G, Gahl WA. Infantile Nephropathic Cystinosis Standards of Care: A Reference for People With Infantile Nephropathic Cystinosis, Their Families, and Medical Team.  Cystinosis Research Network.
https://cystinosis.org/wp-content/uploads/2019/01/CRN_StandardsOfCare_FINAL-1.pdf. Accessed February 10, 2023. 3. Ariceta G et al; Grupo T-CiS.bcn. Nefrologia. 2015;35(3):304-321. 4. Emma F et al. Nephrol Dial Transplant. 2014;29(suppl 4):iv87-iv94. 5. Nesterova N, Gahl WA. Pediatr Nephrol. 2013;28(1):51-59.